Movement Alert｜Charles River Laboratories Rises 7.74% in Regular Trading, CRO Sector Rallies as Multiple Banks Raise Price Targets

Market Focus07-28

On July 28, Charles River Laboratories rose 7.74% in regular trading, trading at $235.42/share, with turnover of $79.61 million. The stock surged amid a broad CRO sector rally coupled with multiple investment bank price target upgrades ahead of the upcoming Q2 earnings release.

Deutsche Bank published a Q2 CRO industry outlook report indicating that macro indicators are trending positively across the board, with AI-related fears subsiding and cyclical recovery forming a dual catalyst. Q2 marked the third-highest quarter for biotech equity financing on record. Meanwhile, several investment banks recently raised their price targets on Charles River: Baird lifted its target from $213 to $255, Morgan Stanley from $220 to $260, and Evercore ISI from $220 to $260, all maintaining overweight or outperform ratings.

The company is scheduled to report Q2 earnings on August 5 before market open, with consensus EPS estimates at $2.72. Within the Life Sciences Tools & Services sector, IQVIA rose 12.54%, Repligen gained 13.22%, Thermo Fisher Scientific advanced 2.84%, and Danaher added 2.11%.

(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/1171366320?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-07-28 22:55","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1171366320","market":"us","top_or_hot":-1,"title":"Movement Alert｜Charles River Laboratories Rises 7.74% in Regular Trading, CRO Sector Rallies as Multiple Banks Raise Price Targets","media":"Market Focus","content":"<p><p>On July 28, Charles River Laboratories rose 7.74% in regular trading, trading at $235.42/share, with turnover of $79.61 million. The stock surged amid a broad CRO sector rally coupled with multiple investment bank price target upgrades ahead of the upcoming Q2 earnings release.</p><p>Deutsche Bank published a Q2 CRO industry outlook report indicating that macro indicators are trending positively across the board, with AI-related fears subsiding and cyclical recovery forming a dual catalyst. Q2 marked the third-highest quarter for biotech equity financing on record. Meanwhile, several investment banks recently raised their price targets on Charles River: Baird lifted its target from $213 to $255, Morgan Stanley from $220 to $260, and Evercore ISI from $220 to $260, all maintaining overweight or outperform ratings.</p><p>The company is scheduled to report Q2 earnings on August 5 before market open, with consensus EPS estimates at $2.72. Within the Life Sciences Tools & Services sector, IQVIA rose 12.54%, Repligen gained 13.22%, Thermo Fisher Scientific advanced 2.84%, and Danaher added 2.11%.</p><p>(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)</p></p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Movement Alert｜Charles River Laboratories Rises 7.74% in Regular Trading, CRO Sector Rallies as Multiple Banks Raise Price Targets</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nMovement Alert｜Charles River Laboratories Rises 7.74% in Regular Trading, CRO Sector Rallies as Multiple Banks Raise Price Targets\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1054767329\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/51943b2858f75e05ca2ebb144b4e626a);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Market Focus </p>\n<p class=\"h-time\">2026-07-28 22:55</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p><p>On July 28, Charles River Laboratories rose 7.74% in regular trading, trading at $235.42/share, with turnover of $79.61 million. The stock surged amid a broad CRO sector rally coupled with multiple investment bank price target upgrades ahead of the upcoming Q2 earnings release.</p><p>Deutsche Bank published a Q2 CRO industry outlook report indicating that macro indicators are trending positively across the board, with AI-related fears subsiding and cyclical recovery forming a dual catalyst. Q2 marked the third-highest quarter for biotech equity financing on record. Meanwhile, several investment banks recently raised their price targets on Charles River: Baird lifted its target from $213 to $255, Morgan Stanley from $220 to $260, and Evercore ISI from $220 to $260, all maintaining overweight or outperform ratings.</p><p>The company is scheduled to report Q2 earnings on August 5 before market open, with consensus EPS estimates at $2.72. Within the Life Sciences Tools & Services sector, IQVIA rose 12.54%, Repligen gained 13.22%, Thermo Fisher Scientific advanced 2.84%, and Danaher added 2.11%.</p><p>(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)</p></p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"CRL","symbol_name":"查尔斯河","start_time":0,"source_url":"","article_id":"1171366320","we_media_id":"1054767329","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1171366320","pubTimestamp":1785250536,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Market Focus","introduction":"Track stock‘s movements and relevant news","home_visible":1,"id":"1054767329","head_image":"https://static.tigerbbs.com/51943b2858f75e05ca2ebb144b4e626a"},"summary":"On July 28, Charles River Laboratories rose 7.74% in regular trading, trading at $235.42/share, with turnover of $79.61 million. The stock surged amid a broad CRO sector rally coupled with multiple...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"CRL":"查尔斯河"},"translate_title":"走势警报|Charles River Laboratories 常规交易中上涨 7.74%，多家银行提高目标价，CRO 板块上涨","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"CRL":1},"content_text":"On July 28, Charles River Laboratories rose 7.74% in regular trading, trading at $235.42/share, with turnover of $79.61 million. The stock surged amid a broad CRO sector rally coupled with multiple investment bank price target upgrades ahead of the upcoming Q2 earnings release.Deutsche Bank published a Q2 CRO industry outlook report indicating that macro indicators are trending positively across the board, with AI-related fears subsiding and cyclical recovery forming a dual catalyst. Q2 marked the third-highest quarter for biotech equity financing on record. Meanwhile, several investment banks recently raised their price targets on Charles River: Baird lifted its target from $213 to $255, Morgan Stanley from $220 to $260, and Evercore ISI from $220 to $260, all maintaining overweight or outperform ratings.The company is scheduled to report Q2 earnings on August 5 before market open, with consensus EPS estimates at $2.72. Within the Life Sciences Tools & Services sector, IQVIA rose 12.54%, Repligen gained 13.22%, Thermo Fisher Scientific advanced 2.84%, and Danaher added 2.11%.(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"1","news_tag":"","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"isLaohu8Offline":false,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.47.0","shortVersion":"4.47.0","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1171366320","isCrawlerRequest":true}